Share this
unlocking the potential of remote microsampling in clinical trials
by Neoteryx Microsampling on Jan 15, 2024 9:00:00 AM
In the rapidly evolving world of clinical research, every detail matters. From the precision of the laboratory equipment to recruiting study participants from a broad geographic area and ensuring the comfort and convenience of those study participants, the quest for better, more efficient clinical trial technologies and methodologies is ongoing. One of the breakthrough technologies that has the potential to overcome many challenges of clinical trials is remote microsampling, or remote specimen collection, for remote clinical trials.
A handful of biotech device companies around the globe are committed to providing researchers who are working in drug development and other areas of pharmaceutical sciences more advanced and user-friendly tools. Remote and minimally invasive approaches to blood sample collection support clinical trials, public health studies and epidemiology studies more effectively and efficiently.
This blog delves into the myriad advantages of remote microsampling devices and how they can help transform the landscape of clinical research.
Study Participants Don't Want to Travel to Your Clinical Trial Site
A major concern in clinical trials is the collection of blood samples. Traditional blood collection methods require study participants to visit clinics or hospitals for frequent or routine blood draws performed by a nurse or phlebotomist.
While blood sampling in clinical trials may be necessary for gathering critical data, it can be inconvenient for study participants, especially for those living in remote or rural areas. In fact, the inconvenience of travel and discomfort of blood draws are obstacles that discourage people from joining clinical trials.
The Promises of Remote Microsampling
With remote blood microsampling devices, such as the Mitra® device based on VAMS® technology or the hemaPEN®, in-person visits to the clinical trial site are no longer a necessity. Remote participation can be a huge game-changer for clinical trials.
Reluctant study recruits may be more likely to join a trial if there is a "mail-in" option. And those who might be inclined to drop out after a few site visits are more likely to stay committed if they can avoid travel and continue participating from home.
Remote devices allow study participants to collect their own blood samples at home and mail them to the research lab using standard mail.
This not only reduces the time and cost of commuting, but also eliminates the need for specialized handling and transport of the samples with dry ice or cold shipping.
The volumetric microsampling devices from Trajan are designed for dried blood sampling. Dried blood samples remain stable at room temperature during shipping. Analyte stability is often significantly improved when the matrix is dried blood versus wet blood.
Remote Microsampling: A Cost-Effective Solution
The economic benefits of remote microsampling are manifold. By eliminating the need for trained staff to perform blood draws for sample collection in a clinic setting, and by reducing the need for cold storage and shipping, microsampling offers substantial cost savings. Moreover, its efficiencies can help accelerate the time to market for new drug therapies, thereby boosting profitability for pharmaceutical companies.
Microsampling and Pediatric Studies
Pediatric studies present unique challenges. Traditional blood sampling methods can be stressful and potentially harmful for children. Many children are frightened of needles, making venipuncture blood draws a source of stress or trauma. Additionally, taking large-volume samples from small children can negatively impact their health.
With finger-stick microsampling, a small lancet is pressed against a fingertip to prick it and draw tiny drops of blood in a minimally invasive process that is nearly painless.
The sampling process rapidly collects very small, "micro-sized" volumes of blood, making it easier and safer for small children. This innovative approach among younger, more vulnerable study cohorts has been backed by numerous case studies, leading to a shift in pediatric clinical trials.
Boosting Recruitment and Retention in Clinical Trials
Microsampling removes the most common barriers to participation in clinical trials.
The flexibility to collect blood samples at home, in school, at the office, or in the car can significantly increase enrollment and diversity.
This remote and portable approach also enhances the comfort and ease for participants, leading to better adherence and retention in clinical trials.
Enabling Hybrid Clinical Trials
The advent of microsampling has made it possible to conduct Decentralized Clinical Trials (DCT) or hybrid clinical trials. After an initial clinic visit, participants can collect their own blood samples and other specimens at home, thus making the clinical trial process more convenient and patient friendly.
Trials are further simplified with microsampling devices that are based on dried matrix sampling, whereby the specimens can dry on/in the devices and remain stable at room temperature during their journey through the mail from the patient to the lab.
Reducing Technical Problems and Sample Risks
Microsampling reduces the risk of sample mishandling and degradation, ensuring analyte compatibility and stability. Our microsampling team at Trajan Scientific and Medical (Trajan) offers technical user guides, application notes and other resources to provide step-by-step guidance for sample collection, sample processing and analysis, and sample storage.
Streamlining Workflow with Automation
Microsampling devices are suited for manual or automated processing and analysis. For example, Mitra microsamples can be processed in the lab using the Mitra® 96-Autorack™ designed for use with automated instruments. This can help streamline and automate sample accessioning and processing. Our Neoteryx microsampling devices can easily integrate with your lab's dried blood spot (DBS) workflow with only minor adjustments.
Easing Logistics and Deployment
Remote microsampling devices make it easy for you to deploy sample collection kits and facilitate the return mailing of collected samples with minimal risk. The Neoteryx® microsampling team at Trajan collaborates with reputable third-party fulfillment companies to handle logistics in regions around the globe, ensuring smooth operations for your clinical trials.
Some Final Thoughts on Remote Microsampling
In conclusion, remote microsampling can be a real game-changer in the world of clinical research. The microsampling team at Trajan is dedicated to helping both large and small pharmaceutical organizations, Contract Research Organizations (CROs), and professionals across the research spectrum leverage the power of microsampling. Whether you are a researcher, a bench scientist, an executive, a lab director, or an operational professional, we are here to help you take your clinical research to the next level.
Do you need to recruit a more diverse study cohort? Do you need to find a low-volume sampling solution for a pediatric study? Are you trying to collect blood samples from study cohorts across a wide geography?
Embrace the future of clinical trials and contact our microsampling team to experience the difference!
Image credits: Trajan, iStock, image commons
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (74)
- Therapeutic Drug Monitoring, TDM (51)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Blood Microsampling, Serology (22)
- Decentralized Clinical Trial (DCT) (22)
- Omics, Multi-Omics (20)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Skin Microsampling, Microbiopsy (12)
- Pharmaceuticals, Drug Development (9)
- Harpera Device (5)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- December 2024 (2)
- November 2024 (1)
- October 2024 (3)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think